Atos reduces Jefferies ATM capacity to $0
Atos Therapeutics, Inc. amended its ATM facility.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Atos Therapeutics, Inc. amended its ATM facility. The prospectus supplement states the company reduced the Maximum Offering Price under its Open Market Sale with Jefferies LLC from $100,000,000 to $0, effective as of February 20, 2026.
No shares have been sold under the ATM Facility as of the date of the supplement.
Insights
Reduction of ATM capacity to zero is an administrative amendment; timing and cash impact depend on subsequent actions.
The supplement explicitly states the Maximum Offering Price under the Open Market Sale with Jefferies LLC was reduced from $100,000,000 to $0 and is effective as of February 20, 2026. The filing also notes that no shares have been sold under the ATM Facility.
This change removes available at‑the‑market capacity; any future ability to sell common stock via the ATM would require a new registration or amendment. Cash‑flow treatment is not discussed in the excerpt.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ATOS change in its ATM facility?
Does the supplement say why ATOS reduced the ATM to $0?
Where can investors find more details about this change?
AI-generated analysis. How Rhea-AI works. Not financial advice.
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-279367
Prospectus Supplement
(To Prospectus dated May 23, 2024)
This prospectus supplement supplements and amends the prospectus dated May 23, 2024 (the “Prospectus”), as supplemented and amended by that certain prospectus supplement dated November 19, 2024 covering the offering, issuance and sale of up to a maximum aggregate offering price of $100,000,000 (the “Maximum Offering Price”) of our common stock that may be issued and sold under an Open Market Sale AgreementSM with Jefferies LLC (the “ATM Facility”).
Effective as of February 20, 2026, we have reduced the Maximum Offering Price to $0. As of the date of this prospectus supplement, no shares have been sold under the ATM Facility.
You should read this prospectus supplement, together with additional information described under the headings “Information Incorporated by Reference” and “Where You Can Find Additional Information” in the Prospectus carefully before you invest in our securities.
Investing in our securities involves a high degree of risk. Before making any investment in our securities, you should consider carefully the risks and uncertainties described in the section entitled “Risk Factors” beginning on page 7 of the Prospectus.
The date of this prospectus supplement is February 20, 2026.